AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Vilmorin & Cie

Capital/Financing Update Mar 14, 2013

1751_iss_2013-03-14_ed710c85-649b-418c-9fc0-abf7b1f973cf.pdf

Capital/Financing Update

Open in Viewer

Opens in native device viewer

Public limited company with Board of Directors, with a capital of 288 833 642,75 Euros Head Office: 4, Quai de la Mégisserie – F-75001 PARIS SIREN Paris 377 913 728 Fiscal year from July 1st to June 30th NYSE Euronext Paris (Compartment A) – Eligible for Deferred Settlement Order

March 14, 2013

Success of a private placement ("Schuldschein") of €130 million Full takeover of Bisco Bio Sciences. India

CONTINUING CONSOLIDATION AND DISINTERMEDIATION OF FINANCIAL RESOURCES

Vilmorin has just successfully completed an inaugural private placement of the "Schuldschein" type, for a total 130 million Euros. This placement comprises maturities at 5, 7 and 10 years, combining fixed and variable rates.

Very largely oversubscribed (x 2.4), this operation has been increased in relation to its initial objective and has been allocated to various investors, mainly European and Asian.

This private placement, which is part of its disintermediation strategy, will enable Vilmorin to reinforce the architecture of its financial resources in very favorable conditions, with the possibility of extending the average maturity of its debt and internationalizing its funding sources. Vilmorin has thus strengthened its financial flexibility to implement its development plan on both the vegetable seeds and field seeds markets.

The launch and arrangement of this placement was entrusted to HSBC Trinkaus & Burkhardt AG.

FULL TAKEOVER OF BISCO BIO SCIENCES. INDIA

Vilmorin has just acquired the remaining 39% of the capital stock of Bisco Bio Sciences from its historical family shareholders.

This transaction thus means that Vilmorin has taken full control of the company.

The operation aims to accelerate the deployment of Vilmorin's activities on the field seeds market in India, which is characterized by a high rate of growth and extremely dynamic development perspectives.

As a reminder, Vilmorin had already purchased an initial majority stake in Bisco Bio Sciences in March 2012, thus becoming one of the main players on the Indian market for hybrid corn seeds.

NEXT DISCLOSURE MONDAY APRIL 29, 2013 (AT THE END OF TRADING): SALES AT THE END OF THE THIRD QUARTER 2012-2013

OTHER DISCLOSURES FOR 2012-2013 (at the end of trading on the Paris stock market)

Wednesday July 31, 2013: sales for fiscal year 2012-2013 Tuesday October 8, 2013: results for fiscal year 2012-2013

As the world's fourth largest seed company, Vilmorin develops vegetable and field seeds with high added value, to better meet global food requirements.

True to its vision of sustainable development, Vilmorin relies on ongoing investments in research and international growth to strengthen its market shares. An ambition that is driven by its corporate culture which is based on the sharing of knowledge, quality of life and respect for the needs of mankind.

For any further information:

Daniel Jacquemond Claire Planche Chief Financial Officer Financial Communication and [email protected] Investor Relations Officer

[email protected]

Tel: + 33 (0)4 73 63 44 85 Fax: + 33 (0)4 73 63 41 80

Website: www.vilmorin.info

Talk to a Data Expert

Have a question? We'll get back to you promptly.